UNSPSC 51385805: Piroxicam

This classification denotes a cyclooxygenase inhibitor and aromatic compound with the molecular formula C15H13N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13T4O6VMAM, chemically known as 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide but generally known as piroxicam, which bears US NIH Compound Identifier 5280452. European Medicines Agency schedules Piroxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09936MIG.

UNSPSC 51385805 Piroxicam is a Commodity code that represents pharmaceutical products, yet the single recent state and local opportunity posted under this code shows a substantial mismatch with the code's nominal scope. Seminole County, Florida issued an IFB in June 2026 for naloxone and safe drug deactivation systems — acute emergency and harm-reduction supplies unrelated to piroxicam, an NSAID pain medication. The code shows little relevant recent activity aligned with its intended pharmaceutical category. State and local procurement offices appear to use this code infrequently or inconsistently for the product it nominally represents, making it difficult to characterize actual buying patterns in the market.

Without additional opportunities clearly aligned to piroxicam procurement, no geographic concentration or repeat-buyer pattern emerges. The Seminole County solicitation (IFB 60459723LAS, due July 26, 2023) does not represent the work typically expected under this Commodity code and should not be treated as a proxy for piroxicam demand. Business development professionals evaluating this code should treat recent activity as sparse and conduct direct outreach to state Medicaid agencies, hospital systems, and health departments to validate whether piroxicam procurement occurs through alternative channels, cooperative agreements, or higher-tier family codes rather than through this specific Commodity designation.